Document is current
Any future updates will be listed below
-
Authors
Soomsawasdi, Piriya
Rojananuangnit, Kulawan https://orcid.org/0000-0001-5459-5562
Arayangkoon, Eakkachai
Chantiwas, Ratchada
Pengrungreungwong, Sureeporn
Preawsampran, Nontakorn
Tinpowong, Natnaree
Samakhararaksakul, Rujira
Katkingkaew, Kanokwan
Seekhum, Natthapuch
Sathim, Wanwisa
-
Clinical Trials BETA
Clinical trials referenced in this document:
tctr20241005001 at Thai Clinical Trials RegistryDocuments that mention this clinical trial
Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections
https://doi.org/10.1007/s40123-024-01081-z
-
Funding
Funding for this research was provided by:
Mettapracharak(Wat Raikhing)Hospital
- License Information
-
More Information
Article History
Received: 6 October 2024
Accepted: 27 November 2024
First Online: 18 December 2024
Declarations
:
: Piriya Soomsawasdi, Kulawan Rojananuangnit, Eakkachai Arayangkoon, Ratchada Chantiwas, Sureeporn Pengrungreungwong, Nontakorn Preawsampran, Natnaree Tinpowong, Rujira Samakhararaksakul, Kanokwan Katkingkaew, Natthapuch Seekhum, and Wanwisa Sathim declare that they have no competing interests.
: This randomized double-blind clinical trial was approved by the Mettapracharak (Wat Rai Khing) Research Ethics Committee in accordance with the International Conference on Harmonization Good Clinical Practice (ICH-GCP) COA No 015/2563. The study was performed in accordance with the Helsinki Declaration of 1964. All participants provided informed consent to participate in the study. All privacy data including hospital number, name, and date of birth were masked and kept confidential.
